|Slideshows|February 13, 2015
8 New FDA-Approved Neurology Drugs
Author(s)Susan Kweskin
The FDA has recently approved a number of drugs for a variety of neurologic disorders, including Parkinson's disease and MS. Here are 8 of the newest.
Advertisement
In the last year, the FDA has approved a number of drugs for a variety of neurologic disorders. Here are 8 of the most recent.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
3
POLARIS-AD Phase 3 Trial of PDE5 Inhibitor AR1001 Completes Treatment Phase With Favorable Safety Profile
4
AD109 Accepted NDA, AXS-12 FDA Submission, Phase 2 CELIA Study Results
5













